Xcout IntelDispatch Biotherapeutics
Dispatch Biotherapeutics is an immunotherapy company with offices in Philadelphia and San Francisco, engineering universal treatments using its Flare platform to overcome and target solid tumors.
Subscribe to see Dispatch Biotherapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Dispatch Biotherapeutics at a glance
Dispatch Biotherapeutics is a biotechnology company headquartered in United States. Xcout tracks 10 named people at Dispatch Biotherapeutics, including Sabah Oney, Ph.D. (Chief Executive Officer). Xcout recorded 12 job postings from Dispatch Biotherapeutics in the last 90 days.
Dispatch Biotherapeutics leadership
- Sabah Oney, Ph.D.Chief Executive Officer
- Chris Wiwi, Ph.D.Chief Technical Officer
- Barbra Sasu, Ph.D.Chief Scientific Officer
- Jennifer FlaisherChief People & Culture Officer
- Mauro Avanzi, M.D., Ph.D.Chief Medical Officer
- Jeff Marrazzo, MBA, MPAFounding Chairman; Co-founder and Former CEO, Spark Therapeutics
4 more named people on record for Dispatch Biotherapeutics, with roles, board committees and tenure — see the full roster →
Hiring at Dispatch Biotherapeutics
Xcout recorded 12 job postings from Dispatch Biotherapeutics in the last 90 days, from a hiring record Xcout has kept since October 2026.
The weekly hiring trend, the roles and locations behind it — see Dispatch Biotherapeutics's hiring signals →
Dispatch Biotherapeutics competitors
A few of Dispatch Biotherapeutics's closest competitors — see the full list of competitors and alternatives →
Avammune Therapeutics is an R&D-driven drug discovery company headquartered in Philadelphia, Pennsylvania. The company focuses on developing novel, modality-agnostic immunotherapies and cancer therapies to address high unmet medical needs in hard-to-treat solid tumors.
Flare Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts, focused on pioneering precision therapeutics.
Carisma Therapeutics is a clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, focused on discovering and developing engineered macrophage-based immunotherapies.
Imvax, Inc. is a clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, focused on developing personalized, whole-cell immunotherapies for the treatment of various cancers.
Daylight Biotherapeutics is a biotechnology holding company operating in stealth mode in the United States. The company is developing a novel T cell engaging technology designed to decouple tumor killing from systemic immune activation.
Context Therapeutics Inc. is a biopharmaceutical company headquartered in Philadelphia, Pennsylvania. It is committed to advancing the treatment of solid tumors through the development of next-generation T cell engaging (TCE) bispecific antibodies.
Get Dispatch Biotherapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Dispatch Biotherapeutics? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Dispatch Biotherapeutics in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access